BIO Statement on CMS Announcement of First 10 Drugs Subject to Price Controls Under IRA | BIO
The Biden Administration today unveiled the first 10 prescription drugs that will be subject to price controls under the Inflation Reduction Act (IRA). Rachel King, BIO interim President and CEO,...
bio.org